2BB score and signals
CytomX Therapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 22 | Weak |
| Quality | 80 | Very Strong |
| Risk | 53 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2008 |
| Employees | 69 |
| 52-week range | $1.72 – $8.20 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-15 | — | -0.1015 | — | $5.30M |
| 2026-11-04 | — | -0.0887 | — | $5.10M |
| 2026-08-06 | — | -0.0791 | — | $12.55M |
| 2026-05-11 | — | -0.1005 | — | $6.41M |
2BBBullish & Bearish